Skip to main content
Extending anastrozole treatment beyond 5 years may benefit postmenopausal HR+ BC patients
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Extending anastrozole treatment beyond 5 years may benefit postmenopausal HR+ BC patients
User login
Username
Password
Reset your password
Concept
Lead
score
Breast Cancer
1
1
Estrogen Receptor-Positive (ER+) Breast Cancer
0
0.85
Breast
0
0.47
Cancer
0
0.47
Postoperative
0
0.47
Receptors
0
0.47
Endocrine Therapy
0
1
Hormonal Therapy
0
0.24
Specialty
Lead
score
Hematology-Oncology
1
1
Pharmacist
0
0.91
Ob/Gyn & Women's Health
0
0.76
Edit Tags